These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 1705278
21. Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments. Ho WZ, Lai JP, Bouhamdan M, Duan L, Pomerantz RJ, Starr SE. AIDS Res Hum Retroviruses; 1998 Nov 20; 14(17):1573-80. PubMed ID: 9840290 [Abstract] [Full Text] [Related]
23. The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro. La Maestra L, Zaninoni A, Marriott JB, Lazzarin A, Dalgleish AG, Barcellini W. Clin Exp Immunol; 2000 Jan 20; 119(1):123-9. PubMed ID: 10606973 [Abstract] [Full Text] [Related]
25. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. Okamoto M, Ono M, Baba M. AIDS Res Hum Retroviruses; 1998 Sep 20; 14(14):1239-45. PubMed ID: 9764907 [Abstract] [Full Text] [Related]
26. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Saville MW, Taga K, Foli A, Broder S, Tosato G, Yarchoan R. Blood; 1994 Jun 15; 83(12):3591-9. PubMed ID: 7911340 [Abstract] [Full Text] [Related]
27. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. Montaner LJ, Griffin P, Gordon S. J Gen Virol; 1994 Dec 15; 75 ( Pt 12)():3393-400. PubMed ID: 7527834 [Abstract] [Full Text] [Related]
28. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. Weissman D, Poli G, Fauci AS. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug 15; 9(5):442-9. PubMed ID: 7627621 [Abstract] [Full Text] [Related]
29. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. Fan ST, Hsia K, Edgington TS. Blood; 1994 Sep 01; 84(5):1567-72. PubMed ID: 7915148 [Abstract] [Full Text] [Related]
30. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Han X, Becker K, Degen HJ, Jablonowski H, Strohmeyer G. Eur J Clin Invest; 1996 Apr 01; 26(4):286-92. PubMed ID: 8732485 [Abstract] [Full Text] [Related]
31. Interleukin (IL)-4 inhibits phorbol-ester induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonist. Goletti D, Kinter AL, Coccia EM, Battistini A, Petrosillo N, Ippolito G, Poli G. Cytokine; 2002 Jan 07; 17(1):28-35. PubMed ID: 11886168 [Abstract] [Full Text] [Related]
32. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. Weissman D, Poli G, Fauci AS. AIDS Res Hum Retroviruses; 1994 Oct 07; 10(10):1199-206. PubMed ID: 7848677 [Abstract] [Full Text] [Related]
33. Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression. Goletti D, Kinter AL, Biswas P, Bende SM, Poli G, Fauci AS. J Virol; 1995 Apr 07; 69(4):2540-6. PubMed ID: 7884904 [Abstract] [Full Text] [Related]
34. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M. J Leukoc Biol; 2007 Nov 07; 82(5):1212-20. PubMed ID: 17704294 [Abstract] [Full Text] [Related]
35. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. J Exp Med; 1989 Mar 01; 169(3):1137-51. PubMed ID: 2466937 [Abstract] [Full Text] [Related]
36. Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz. Prochaska HJ, Bornmann WG, Baron P, Polsky B. Mol Pharmacol; 1995 Jul 01; 48(1):15-20. PubMed ID: 7542738 [Abstract] [Full Text] [Related]
37. Effects of glutathione precursors on human immunodeficiency virus replication. Simon G, Moog C, Obert G. Chem Biol Interact; 1994 Jun 01; 91(2-3):217-24. PubMed ID: 8194136 [Abstract] [Full Text] [Related]
38. Mechanisms for macrophage-mediated HIV-1 induction. Devadas K, Hardegen NJ, Wahl LM, Hewlett IK, Clouse KA, Yamada KM, Dhawan S. J Immunol; 2004 Dec 01; 173(11):6735-44. PubMed ID: 15557166 [Abstract] [Full Text] [Related]
39. Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. Barcellini W, Colombo G, La Maestra L, Clerici G, Garofalo L, Brini AT, Lipton JM, Catania A. J Leukoc Biol; 2000 Nov 01; 68(5):693-9. PubMed ID: 11073109 [Abstract] [Full Text] [Related]
40. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. Yang JY, Schwartz A, Henderson EE. AIDS Res Hum Retroviruses; 1993 Aug 01; 9(8):747-54. PubMed ID: 7692906 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]